SlideShare uma empresa Scribd logo
1 de 77
Baixar para ler offline
The UC San Diego AntiViral Research Center sponsors weekly
presentations by infectious disease clinicians, physicians and
researchers. The goal of these presentations is to provide the most
current research, clinical practices and trends in HIV, HBV, HCV, TB
and other infectious diseases of global significance.
The slides from the AIDS Clinical Rounds presentation that you are
about to view are intended for the educational purposes of our
audience. They may not be used for other purposes without the
presenter’s express permission.
AIDS CLINICAL ROUNDS
History
• 56 y.o Caucasian gay man with longstanding HIV
infection presents with fever and rash
• HIV diagnosed in 1986 – initially not in care
• Presented with PCP in 1994; Nadir CD4 count <10
cells/mm3
• Initiated antiretroviral therapy and did well with
CD4 count 382 cells/mm3 (18%) by Feb 2011
• HIV RNA (viral load) <48 copies/mL (undetectable)
• In autumn 2011 noted onset of fatigue, malaise
• Noted to have mildly elevated AST, ALT (new)
Biopsy results
• Liver biopsy 2/29/2012
– MILD TO MODERATELY ACTIVE INTERFACE AND LOBULAR
HEPATITIS WITH PLASMA CELLS AND MILD PERIPORTAL
CHOLESTASIS. PERIPORTAL AND PORTAL-PORTAL BRIDGING
FIBROSIS ARE SEEN IN ASSOCIATION WITH THE
INFLAMMATION
– SUSPICIOUS FOR AUTOIMMUNE HEPATITIS
Treatment
• Treatment for autoimmune hepatitis :
– Prednisone at 60mg started on 5 March 2012
– Azathioprine 150mg daily added on 13 March
• Approximately 48 hours after starting
azathioprine, rash developed
– Mainly on extremities
– Non-tender, non-pruritic
• Subsequently noted fever to 101.6 F
• Worsening malaise and fatigue
History
• Medications:
– Antiretroviral regimen:
• Raltegravir, Emtricitabine/Tenofovir
– Azathioprine 150mg daily
– Prednisone taper – now 15 mg daily
– Acyclovir 400mg BID (HSV prophylaxis)
– Testosterone replacement (gel)
– Atorvastatin 10mg once daily
Physical Examination
• T 38.9 C BP 112/52 HR 96 RR 16
• O2 sat 97% on 2L
• Alert and oriented, well-appearing
• Exam unremarkable except for rash
– Pale macular rash primarily involving palms, soles
– Extends to thighs and distal arms
– Spares trunk
Laboratory studies
• CBC:
– WBC 10.9 (72% N, 1% eos), Hgb 12.9, Plt 317
• Chemistries: Na 127, K 4.5, Cr 1.2
• ALT 55, AST 40, Alk phos 198, Alb 3.3
• U/A unremarkable
• CXR: no acute abnormalities
RPR reactive 1:256 – T. pallidum EIA positive
Update
• Liver biopsy 2/29
– MILD TO MODERATELY ACTIVE INTERFACE AND LOBULAR HEPATITIS WITH
PLASMA CELLS AND MILD PERIPORTAL CHOLESTASIS. PERIPORTAL AND
PORTAL-PORTAL BRIDGING FIBROSIS ARE SEEN IN ASSOCIATION WITH THE
INFLAMMATION SUSPICIOUS FOR AUTOIMMUNE HEPATITIS
• Addendum 4/10:
– Scattered spirochetes are present in the biopsy, seen only
using the immunohistochemical stain. Liver involvement in
secondary syphilis has been associated with bile ductular
proliferation and associated neutrophils, both of which were
identified in this case in addition to the more typical features of
autoimmune hepatitis (plasma cell-rich lobular and interface
hepatitis).
Some lessons from the case
• Syphilis can mimic many diseases
– the “Great Imitator”
– In this case - autoimmune hepatitis
• Current epidemic occurring disproportionately
in MSM, many with HIV infection
• STDs occur in persons over the age of 25 –
even over 55!
Return of the Great Imitator
Syphilis 2013
Charles Hicks, MD
Professor of Medicine
Duke University Medical Center
“Know syphilis in all its
manifestations and
relations, and all other
things clinical will be
added unto you.”
- Sir William Osler
History
 The first description of syphilis occurred during
and after the 1494 siege of Naples.
 Charles VIII invaded with 30,000 mercenary
soldiers who spread out over Europe after the
army was disbanded.
 They brought with them a mysterious new
illness known first as “the Neopolitan disease,”
later as the “French sickness” and “great pox.”
 During the 19th century the term syphilis became
universally accepted.
History
 Origins of syphilis in Europe uncertain
 Confused earlier with other diseases?
 Columbian theory
 Syphilis was endemic in New World
 Spread to Europe from returning sailors
 Whatever its origins, an aggressive form of
syphilis arose in the late 15th century -
“The Great Pox”
Girolamo Frascatoro 1483-1553
“In Englyshe Morbus Gallicus is named the
french pockes, whan than I was young they were
named the spanyshe pockes, the which be of
many kynds of the pockes…. The cause of these
impediments or infyrmytes doth come many
wayes…but specially it is taken when one pocky
person doth synne in lechary the one with
another. All the kinds of pockes be infectiouse.”
- Breviary of Healthe
Andrew Boord, 1547
Sick Report - Frigate “United States”
March 17, 1810
Dr. Julius Wagner-Jauregg
1927 Nobel Prize for Medicine for his discovery of “the therapeutic value
of malaria inoculation in the treatment of dementia paralytica”
Syphilis - Penicillin
• 1943 - John Mahoney reported first trial of
penicillin in syphilis
• Four patients with early syphilis given
25,000 units penicillin IM q4h for 8 days
• Darkfield became negative within 16 hours
• Total dose was 1.2 million units - this
remains a magical number in syphilis
therapy to this date.
Famous Persons with Syphilis
• Ivan the Terrible
• Peter the Great
• Catherine the Great
• Henry VIII of England
• Fredrich Nietzsche
• Albrecht Durer
• Benvenuto Cellini
• Guy de Maupassant
• Benito Mussolini
• Giovanni Cassanova
• Paul Gauguin
• Francisco Goya
• Vincent van Gogh
• John Keats
• Oscar Wilde
• Franz Schubert
• Moliere
• Heinrich Heine
1972 - Peter Buxton, a
PHS official, complained
to a reporter about an
ongoing study of syphilis
being conducted in black
men living in Alabama.
The resulting stories in the NY
Times and Washington Star
created an uproar
Congressional hearings
convened and an outrageous
story was revealed
Tuskegee
• 1932: Study begins with about 600 black men
(more than 400 of whom had syphilis).
– Most are poor and uneducated
– Most from Tuskegee, Alabama, an area with the highest
syphilis rate in the U.S.
• Incentives for enrollment
– Free transportation to the hospital
– Free hot lunches
– Free medicine for any disease other than syphilis
– Free burial after autopsies were performed.
• By late 1940’s penicillin established as curative
for persons with syphilis, yet treatment not
provided to these men until decades later.
Tuskegee
• Understandably, the outrage was enormous,
especially in the African-American community
• Damage to the relationship with public health
community has been enduring and profound.
• This legacy of suspicion and distrust has made
public health and research efforts in HIV among
African-Americans extremely problematic.
– Belief among many African-Americans that HIV/AIDS is a
form of genocide that may have been created in a
laboratory does not seem so outlandish
• The Tuskegee study became for many blacks “a
symbol of their mistreatment by the medical
establishment, a metaphor for deceit, conspiracy,
malpractice, and neglect, if not outright racial
genocide.”
Remnants of the Tuskegee
Syphilis Study Effects on
University Freshmen: Yet a
Possible Barrier to Research
Participation?
Crystal B. Spivey, MPH, DrPH
March 9, 2004
Supported by: R24MD00151 NCMHD
Syphilis - Epidemiology
• Worldwide >12 million cases of syphilis annually
– 90% in the developing world
• U.S. cases peaked near the end of WWII, then fell
dramatically with the introduction of penicillin
• Mini-epidemic in late 1980s and early 1990s, then
declining to lowest level ever in 2000 (eradication?)
• Significant increase in cases thereafter which
continues….
Syphilis—Reported Cases by Stage of
Infection, United States, 1941–2011
2011-Fig 36. SR
Primary and Secondary Syphilis—Rates by Sex and
Male-to-Female Rate Ratios, United States, 1990–
2011
2011-Fig 38. SR
Primary and Secondary Syphilis—Rates by
Race/Ethnicity, United States, 2002–2011
2011-Fig 45. SR
Primary and Secondary Syphilis—Reported
Cases* by Sex, Sexual Behavior, and
Race/Ethnicity, United States, 2011
*Of the reported male cases of primary and secondary syphilis, 17.0% were missing sex of sex partner
information; 2.4% of sex partner data were missing race/ethnicity data.
†MSW=men who have sex with women only; MSM=men who have sex with men;
2011-Fig 47. SR
Primary and Secondary Syphilis—Rates by
Region, United States, 2002–2011
2011-Fig 39. SR
Trends in Internet Use for Sexual Encounters
by MSM with Syphilis: 2001 - 2003
17.4
20.8
26.7
0
5
10
15
20
25
30
PercentInternetusers
2001 2002 2003
Report Year
(N=899)
LAC - DHS
“The pleasure is
momentary, the position
ridiculous, and the expense
damnable”
-Attributed to Lord Chesterfield
Pathophysiology
 Syphilis is caused by the
spirochete Treponema
pallidum.
 It initiates infection after
gaining access to
subcutaneous tissues via
abrasions that occur
during sexual intercourse
 Can initiate infection on
intact skin
Pathophysiology
 After invading the
subcutaneous tissue the
organism establishes
the chancre.
 Some organisms also
establish infection in
regional lymph nodes
during early local
replication.
Pathophysiology
 Nearly all cases of syphilis are sexually acquired
(aside from congenital syphilis)
 Transmission rate during primary and secondary
syphilis is about 30% and requires exposure to
open lesions – either primary chancre or
mucocutaneous lesions.
 The incubation period varies but ranges from 10 –
90 days.
Clinical manifestations:
Primary syphilis
 The initial clinical manifestations is the primary
chancre.
 Usually painless, which distinguishes it from other
causes of genital ulcers: herpes simplex (genital
herpes) and Hemophilus ducreyi (chancroid).
 May be indurated (collar button)
 Most often heals without treatment over a period of
a few weeks.
Secondary syphilis
 If untreated,
approximately 25% of
patients will go on to
develop systemic
symptoms
 Rash
 Fever
 Headache
 Malaise
 Diffuse lymphadenopathy
 Alopecia
Secondary syphilis
Secondary Syphilis - Patchy Alopecia
Late vs. Latent syphilis
 Latent syphilis refers to patients without symptoms
who have positive serologic testing for syphilis.
 Early latent refers to duration less than one year
 Late latent refers to duration greater than one year or of
unknown duration
 Late or tertiary syphilis refers to the group of
clinical manifestations that may occur anywhere
between 1 and 30 years after infection when the
infection is not treated.
Tertiary syphilis
 Patients may not have
experienced symptomatic
primary or secondary
syphilis prior to developing
tertiary syphilis
 Most common
manifestations are central
nervous system, the
cardiovascular system, or
the skin and subcutaneous
tissues (gummas).
Neurosyphilis
 Neurosyphilis refers to invasion of the CSF by T.
pallidum and can occur at any stage of disease
 Early in the disease the most common manifestations
are asymptomatic meningitis, symptomatic meningitis,
and meningovascular disease.
 Late in disease, the most common forms involve the
brain and spinal cord parenchyma (general paresis
[progressive dementia] and tabes dorsalis).
Asymptomatic neurosyphilis
 By definition, no symptoms or signs of CNS
involvement
 Can occur within weeks of infection
 Characterized by lymphocytic pleocytosis typically <100 cells/µL, an
elevated protein concentration usually <100 mg/dL, a reactive VDRL, or
a combination of these.
 CSF WBC count >10 lymphocytes per microliter + a protein
concentration >45 mg/dL in patients without HIV infection is suggestive
 Reactive CSF-VDRL is diagnostic of neurosyphilis
 In HIV-infected patients with a negative CSF VDRL the diagnosis is
challenging since a mild CSF pleocytosis and elevated protein are
relatively common in HIV-infected patients
Syphilis and HIV
 HIV and syphilis are prevalent in the same risk groups,
particularly men who have sex with men (MSM)
 The two infections can enhance the acquisition and transmission
of one other
 Neurosyphilis may be more common in persons co-infected with
HIV; there have been many case reports of HIV+ patients
rapidly progressing from early syphilis to neurosyphilis
 Failure of benzathine penicillin to cross blood-brain barrier
may be more problematic in HIV-infected persons with syphilis
Syphilis and HIV Infection
• More florid presentations of early syphilis
• More rapid progression to symptomatic
neurosyphilis after early infection
• Risk of benzathine penicillin treatment failure -
CNS
• Delayed seroconversion (RPR, FTA-Abs) in early
syphilis
• Potential for sero-reversion of treponemal
serology
• Unusually high titer non-treponemal serologic
results
Nonetheless, most cases managed as if HIV-
negative
Syphilis and HIV
Aberrant Serologic Testing for Syphilis
• HIV-positive patients with syphilis often have higher
titers of reagin antibodies than HIV-uninfected
individuals.
• However, some patients with very late stage HIV
infection have delayed or absent serologic responses
(i.e., false negative tests), or are more likely to lose
their reactivity after appropriate therapy.
• This variability is thought to reflect abnormally active
B-cell function during early HIV infection and B-cell
failure during late stage infection.
Syphilis and HIV
Aberrant Serologic Testing for Syphilis
• The rate of decline of nontreponemal titers
following successful therapy may also be
influenced by HIV co-infection, falling more slowly
in those with HIV infection.
• In a large, randomized prospective study of persons
with early syphilis, the HIV-coinfected group had a
higher rate of serologically defined treatment
failure.
• However, in this and other studies, all patients
responded clinically to treatment, suggesting that
the significance of the diminished serologic
response may be minimal.
Diagnosis
 T. pallidum cannot be grown
in culture, so other methods
have been used to identify
organisms
 Dark field microscopy - direct
visualization of spirochetes taken
directly from lesions
 Direct fluorescent antibody
testing was previously used –
detected T. pallidum-specific
antigens
 Neither test currently available
 More often, serologic tests
are used, traditionally:
 Nontreponemal tests (VDRL and
RPR) measure reactivity of serum
from patients with syphilis to a
cardiolipin-cholesterol-lecithin
antigen. They measure IgG and
IgM antibodies and are reported
as titers.
 Treponemal tests (FTA-ABS, MHA-
TP and TPPA) are based upon the
detection of antibodies directed
against treponemal cellular
components.
If asymptomatic, who needs LP?
 Study of 239 patients with syphilis who
underwent LP analyzed to determine
predictors for neurosyphilis
 Neurosyphilis defined as +CSF VDRL and/or
CSF WBC > 20 cells/ml
 43 of 239 met diagnostic criteria. Predictors:
 Serum RPR > 1:32
 HIV infection with CD4 count < 350 cells /mm3
Marra et al. J Infect Dis 2004;189:369-76
Treatment of Syphilis
Treatment
 T. pallidum remains highly sensitive to penicillin and no resistance has been
reported to date despite several decades of use
Treatment
 Successful therapy requires maintenance of prolonged low concentrations of
drug in infected tissues
 Depot preparations such as benzathine penicillin accomplish this goal but
do not penetrate CNS
 Standard therapy for primary, secondary, or early latent syphilis is
benzathene penicillin G (one dose 2.4 million units IM)
 If the patient has had syphilis of greater than 1 year duration or if duration
is unknown, treatment should be benzathene penicillin G 2.4 million units IM
x 3 weekly doses
 Neurosyphilis and ocular syphilis: 18 to 24 million units per day,
administered as 3 to 4 million units IV every four hours or continuous
infusion, for 10 to 14 days
“Half of what we have taught
you is wrong. Unfortunately,
we do not know which half.”
– C. Sidney Burwell, M.D.
Address to the graduation class
Harvard Medical School

Mais conteúdo relacionado

Mais procurados

Seminar on inguinal bubo syndrome.yih
Seminar on inguinal bubo syndrome.yihSeminar on inguinal bubo syndrome.yih
Seminar on inguinal bubo syndrome.yih
myihienew
 
Sexually Transmitted Diseases and Pelvic Inflammatry diseases
Sexually Transmitted Diseases and Pelvic Inflammatry diseasesSexually Transmitted Diseases and Pelvic Inflammatry diseases
Sexually Transmitted Diseases and Pelvic Inflammatry diseases
gelaye mandefro
 
Urethra and male genital system
Urethra and male genital systemUrethra and male genital system
Urethra and male genital system
Saurav Singh
 

Mais procurados (20)

Opportunistic infections in hiv
Opportunistic infections in hivOpportunistic infections in hiv
Opportunistic infections in hiv
 
[Micro] syphilis
[Micro] syphilis[Micro] syphilis
[Micro] syphilis
 
Cutaneous manifestations of hiv infection
Cutaneous manifestations of hiv infectionCutaneous manifestations of hiv infection
Cutaneous manifestations of hiv infection
 
Toxoplasmosis
ToxoplasmosisToxoplasmosis
Toxoplasmosis
 
Wilms tumor
Wilms tumorWilms tumor
Wilms tumor
 
congenital herpes infection
congenital herpes infectioncongenital herpes infection
congenital herpes infection
 
Sexually transmitted diseases
Sexually transmitted diseasesSexually transmitted diseases
Sexually transmitted diseases
 
Seminar on inguinal bubo syndrome.yih
Seminar on inguinal bubo syndrome.yihSeminar on inguinal bubo syndrome.yih
Seminar on inguinal bubo syndrome.yih
 
Sexually Transmitted Diseases and Pelvic Inflammatry diseases
Sexually Transmitted Diseases and Pelvic Inflammatry diseasesSexually Transmitted Diseases and Pelvic Inflammatry diseases
Sexually Transmitted Diseases and Pelvic Inflammatry diseases
 
Urethra and male genital system
Urethra and male genital systemUrethra and male genital system
Urethra and male genital system
 
Pruritus
PruritusPruritus
Pruritus
 
Syphilis
Syphilis Syphilis
Syphilis
 
Drug eruptions
Drug eruptionsDrug eruptions
Drug eruptions
 
Bullous diseases
Bullous diseasesBullous diseases
Bullous diseases
 
tick borne encephalitis
tick borne encephalitistick borne encephalitis
tick borne encephalitis
 
Parvovirus b19 infection
Parvovirus b19 infectionParvovirus b19 infection
Parvovirus b19 infection
 
Non gonococcal urethritis
Non gonococcal urethritisNon gonococcal urethritis
Non gonococcal urethritis
 
Dermatology in HIV
Dermatology in HIVDermatology in HIV
Dermatology in HIV
 
Tularemia.ppt
Tularemia.pptTularemia.ppt
Tularemia.ppt
 
Herpes simplex
Herpes simplexHerpes simplex
Herpes simplex
 

Destaque

Microbiology Ch 24 lecture_presentation
Microbiology Ch 24 lecture_presentationMicrobiology Ch 24 lecture_presentation
Microbiology Ch 24 lecture_presentation
TheSlaps
 
Syphilis co-infection among persons living with HIV infection in Shelby Count...
Syphilis co-infection among persons living with HIV infection in Shelby Count...Syphilis co-infection among persons living with HIV infection in Shelby Count...
Syphilis co-infection among persons living with HIV infection in Shelby Count...
CDC NPIN
 
Neisseria - Prac. Microbiology
Neisseria - Prac. MicrobiologyNeisseria - Prac. Microbiology
Neisseria - Prac. Microbiology
CU Dentistry 2019
 

Destaque (17)

Treponema pallidum tutorial
Treponema pallidum tutorial Treponema pallidum tutorial
Treponema pallidum tutorial
 
SYPHILIS - TREPONEMA PALLIDUM
SYPHILIS - TREPONEMA PALLIDUMSYPHILIS - TREPONEMA PALLIDUM
SYPHILIS - TREPONEMA PALLIDUM
 
Microbiology lec6
Microbiology   lec6Microbiology   lec6
Microbiology lec6
 
Granulomatous diseases of nose
Granulomatous diseases of noseGranulomatous diseases of nose
Granulomatous diseases of nose
 
Sti's updated-What you need to know
Sti's updated-What you need to knowSti's updated-What you need to know
Sti's updated-What you need to know
 
Microbiology Ch 24 lecture_presentation
Microbiology Ch 24 lecture_presentationMicrobiology Ch 24 lecture_presentation
Microbiology Ch 24 lecture_presentation
 
Syphilis co-infection among persons living with HIV infection in Shelby Count...
Syphilis co-infection among persons living with HIV infection in Shelby Count...Syphilis co-infection among persons living with HIV infection in Shelby Count...
Syphilis co-infection among persons living with HIV infection in Shelby Count...
 
Neisseria - Prac. Microbiology
Neisseria - Prac. MicrobiologyNeisseria - Prac. Microbiology
Neisseria - Prac. Microbiology
 
Syphilis(Treponema pallidum)
Syphilis(Treponema pallidum)Syphilis(Treponema pallidum)
Syphilis(Treponema pallidum)
 
Microbiology Unit 2-3: Bacteria
Microbiology Unit 2-3: BacteriaMicrobiology Unit 2-3: Bacteria
Microbiology Unit 2-3: Bacteria
 
Neisseria, gonorrhoea, STD, meningitis, meningococci, gonococci, bacterial in...
Neisseria, gonorrhoea, STD, meningitis, meningococci, gonococci, bacterial in...Neisseria, gonorrhoea, STD, meningitis, meningococci, gonococci, bacterial in...
Neisseria, gonorrhoea, STD, meningitis, meningococci, gonococci, bacterial in...
 
T. Pallidum
T. PallidumT. Pallidum
T. Pallidum
 
Treponema Pallidum
Treponema PallidumTreponema Pallidum
Treponema Pallidum
 
Syphilis PPT
Syphilis PPTSyphilis PPT
Syphilis PPT
 
Gonorrhea
GonorrheaGonorrhea
Gonorrhea
 
Significant bacteriuria
Significant bacteriuriaSignificant bacteriuria
Significant bacteriuria
 
Treponema Pallidum - Microbiología
Treponema Pallidum - MicrobiologíaTreponema Pallidum - Microbiología
Treponema Pallidum - Microbiología
 

Semelhante a The Great Imitator in 2013 – Syphilis and HIV Infection

Power point presentation -The History of HIV/AIDS
Power point presentation -The History of HIV/AIDSPower point presentation -The History of HIV/AIDS
Power point presentation -The History of HIV/AIDS
Sol Velazquez
 
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docxNATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
vannagoforth
 
Hiv classics11252013
Hiv classics11252013Hiv classics11252013
Hiv classics11252013
pkhohl
 
seminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdfseminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdf
mZOn2
 
Friis chapter 1 slides
Friis chapter 1 slidesFriis chapter 1 slides
Friis chapter 1 slides
todd.damrow
 

Semelhante a The Great Imitator in 2013 – Syphilis and HIV Infection (20)

Power point presentation -The History of HIV/AIDS
Power point presentation -The History of HIV/AIDSPower point presentation -The History of HIV/AIDS
Power point presentation -The History of HIV/AIDS
 
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docxNATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCEBad Blo.docx
 
Hiv history
Hiv historyHiv history
Hiv history
 
Hiv classics11252013
Hiv classics11252013Hiv classics11252013
Hiv classics11252013
 
06 cohort studies
06 cohort studies06 cohort studies
06 cohort studies
 
06 cohort studies
06 cohort studies06 cohort studies
06 cohort studies
 
Clinical microbiology and molecular techniques
Clinical microbiology and molecular techniquesClinical microbiology and molecular techniques
Clinical microbiology and molecular techniques
 
Co relation of csf and neurological findings in hiv positive patients
Co relation of csf and neurological findings in hiv positive patientsCo relation of csf and neurological findings in hiv positive patients
Co relation of csf and neurological findings in hiv positive patients
 
Tracing the History of HIV: Exploring Controversial Points
Tracing the History of HIV: Exploring Controversial PointsTracing the History of HIV: Exploring Controversial Points
Tracing the History of HIV: Exploring Controversial Points
 
Darc foundation covid 19-2
Darc foundation covid 19-2Darc foundation covid 19-2
Darc foundation covid 19-2
 
Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.  Epidemiology & Control measures for Tuberculosis.
Epidemiology & Control measures for Tuberculosis.
 
AIDS and Its Oral Manifestation
AIDS and Its Oral ManifestationAIDS and Its Oral Manifestation
AIDS and Its Oral Manifestation
 
seminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdfseminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdf
 
Seminar on hiv
Seminar on hivSeminar on hiv
Seminar on hiv
 
Kenya Higgs 2.9.2016
Kenya Higgs 2.9.2016Kenya Higgs 2.9.2016
Kenya Higgs 2.9.2016
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 
HIV History & Epidemiology by Dr Karl Henson
HIV History & Epidemiology by Dr Karl HensonHIV History & Epidemiology by Dr Karl Henson
HIV History & Epidemiology by Dr Karl Henson
 
Friis chapter 1 slides
Friis chapter 1 slidesFriis chapter 1 slides
Friis chapter 1 slides
 
Ebola final
Ebola finalEbola final
Ebola final
 
Ebola
EbolaEbola
Ebola
 

Mais de UC San Diego AntiViral Research Center

Mais de UC San Diego AntiViral Research Center (20)

10.20.23 | Frailty in People Aging with HIV
10.20.23 | Frailty in People Aging with HIV10.20.23 | Frailty in People Aging with HIV
10.20.23 | Frailty in People Aging with HIV
 
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
 
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
 
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
 
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
 
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
 
02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
 
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
 
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
 
10.23.20 | Rise Above COVID (Treatments for COVID-19)
10.23.20 | Rise Above COVID (Treatments for COVID-19)10.23.20 | Rise Above COVID (Treatments for COVID-19)
10.23.20 | Rise Above COVID (Treatments for COVID-19)
 
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
 
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
 
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
 

Último

Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
chetankumar9855
 
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
Call Girls In Delhi Whatsup 9873940964 Enjoy Unlimited Pleasure
 

Último (20)

Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Rishikesh Just Call 8250077686 Top Class Call Girl Service Available
 
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Hosur Just Call 9630942363 Top Class Call Girl Service Available
 
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
Call Girl In Pune 👉 Just CALL ME: 9352988975 💋 Call Out Call Both With High p...
 
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service AvailableCall Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
Call Girls Vadodara Just Call 8617370543 Top Class Call Girl Service Available
 
Top Rated Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
Top Rated  Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...Top Rated  Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
Top Rated Hyderabad Call Girls Chintal ⟟ 9332606886 ⟟ Call Me For Genuine Se...
 
Russian Call Girls Service Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
Russian Call Girls Service  Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...Russian Call Girls Service  Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
Russian Call Girls Service Jaipur {8445551418} ❤️PALLAVI VIP Jaipur Call Gir...
 
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
🌹Attapur⬅️ Vip Call Girls Hyderabad 📱9352852248 Book Well Trand Call Girls In...
 
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
 
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
All Time Service Available Call Girls Marine Drive 📳 9820252231 For 18+ VIP C...
 
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
Call Girls Service Jaipur {8445551418} ❤️VVIP BHAWNA Call Girl in Jaipur Raja...
 
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
 
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...Top Rated Bangalore Call Girls Mg Road ⟟   9332606886 ⟟ Call Me For Genuine S...
Top Rated Bangalore Call Girls Mg Road ⟟ 9332606886 ⟟ Call Me For Genuine S...
 
Call Girls Kurnool Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kurnool Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Kurnool Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kurnool Just Call 8250077686 Top Class Call Girl Service Available
 
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
The Most Attractive Hyderabad Call Girls Kothapet 𖠋 9332606886 𖠋 Will You Mis...
 
Call Girls Guntur Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Guntur  Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Guntur  Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Guntur Just Call 8250077686 Top Class Call Girl Service Available
 
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
Jogeshwari ! Call Girls Service Mumbai - 450+ Call Girl Cash Payment 90042684...
 
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
Night 7k to 12k Navi Mumbai Call Girl Photo 👉 BOOK NOW 9833363713 👈 ♀️ night ...
 
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony 📳 7877925207 For 18+ VIP Call Girl At Th...
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
 

The Great Imitator in 2013 – Syphilis and HIV Infection

  • 1. The UC San Diego AntiViral Research Center sponsors weekly presentations by infectious disease clinicians, physicians and researchers. The goal of these presentations is to provide the most current research, clinical practices and trends in HIV, HBV, HCV, TB and other infectious diseases of global significance. The slides from the AIDS Clinical Rounds presentation that you are about to view are intended for the educational purposes of our audience. They may not be used for other purposes without the presenter’s express permission. AIDS CLINICAL ROUNDS
  • 2. History • 56 y.o Caucasian gay man with longstanding HIV infection presents with fever and rash • HIV diagnosed in 1986 – initially not in care • Presented with PCP in 1994; Nadir CD4 count <10 cells/mm3 • Initiated antiretroviral therapy and did well with CD4 count 382 cells/mm3 (18%) by Feb 2011 • HIV RNA (viral load) <48 copies/mL (undetectable) • In autumn 2011 noted onset of fatigue, malaise • Noted to have mildly elevated AST, ALT (new)
  • 3. Biopsy results • Liver biopsy 2/29/2012 – MILD TO MODERATELY ACTIVE INTERFACE AND LOBULAR HEPATITIS WITH PLASMA CELLS AND MILD PERIPORTAL CHOLESTASIS. PERIPORTAL AND PORTAL-PORTAL BRIDGING FIBROSIS ARE SEEN IN ASSOCIATION WITH THE INFLAMMATION – SUSPICIOUS FOR AUTOIMMUNE HEPATITIS
  • 4. Treatment • Treatment for autoimmune hepatitis : – Prednisone at 60mg started on 5 March 2012 – Azathioprine 150mg daily added on 13 March • Approximately 48 hours after starting azathioprine, rash developed – Mainly on extremities – Non-tender, non-pruritic • Subsequently noted fever to 101.6 F • Worsening malaise and fatigue
  • 5. History • Medications: – Antiretroviral regimen: • Raltegravir, Emtricitabine/Tenofovir – Azathioprine 150mg daily – Prednisone taper – now 15 mg daily – Acyclovir 400mg BID (HSV prophylaxis) – Testosterone replacement (gel) – Atorvastatin 10mg once daily
  • 6. Physical Examination • T 38.9 C BP 112/52 HR 96 RR 16 • O2 sat 97% on 2L • Alert and oriented, well-appearing • Exam unremarkable except for rash – Pale macular rash primarily involving palms, soles – Extends to thighs and distal arms – Spares trunk
  • 7.
  • 8.
  • 9. Laboratory studies • CBC: – WBC 10.9 (72% N, 1% eos), Hgb 12.9, Plt 317 • Chemistries: Na 127, K 4.5, Cr 1.2 • ALT 55, AST 40, Alk phos 198, Alb 3.3 • U/A unremarkable • CXR: no acute abnormalities RPR reactive 1:256 – T. pallidum EIA positive
  • 10. Update • Liver biopsy 2/29 – MILD TO MODERATELY ACTIVE INTERFACE AND LOBULAR HEPATITIS WITH PLASMA CELLS AND MILD PERIPORTAL CHOLESTASIS. PERIPORTAL AND PORTAL-PORTAL BRIDGING FIBROSIS ARE SEEN IN ASSOCIATION WITH THE INFLAMMATION SUSPICIOUS FOR AUTOIMMUNE HEPATITIS • Addendum 4/10: – Scattered spirochetes are present in the biopsy, seen only using the immunohistochemical stain. Liver involvement in secondary syphilis has been associated with bile ductular proliferation and associated neutrophils, both of which were identified in this case in addition to the more typical features of autoimmune hepatitis (plasma cell-rich lobular and interface hepatitis).
  • 11.
  • 12. Some lessons from the case • Syphilis can mimic many diseases – the “Great Imitator” – In this case - autoimmune hepatitis • Current epidemic occurring disproportionately in MSM, many with HIV infection • STDs occur in persons over the age of 25 – even over 55!
  • 13. Return of the Great Imitator Syphilis 2013 Charles Hicks, MD Professor of Medicine Duke University Medical Center
  • 14. “Know syphilis in all its manifestations and relations, and all other things clinical will be added unto you.” - Sir William Osler
  • 15. History  The first description of syphilis occurred during and after the 1494 siege of Naples.  Charles VIII invaded with 30,000 mercenary soldiers who spread out over Europe after the army was disbanded.  They brought with them a mysterious new illness known first as “the Neopolitan disease,” later as the “French sickness” and “great pox.”  During the 19th century the term syphilis became universally accepted.
  • 16. History  Origins of syphilis in Europe uncertain  Confused earlier with other diseases?  Columbian theory  Syphilis was endemic in New World  Spread to Europe from returning sailors  Whatever its origins, an aggressive form of syphilis arose in the late 15th century - “The Great Pox”
  • 18.
  • 19. “In Englyshe Morbus Gallicus is named the french pockes, whan than I was young they were named the spanyshe pockes, the which be of many kynds of the pockes…. The cause of these impediments or infyrmytes doth come many wayes…but specially it is taken when one pocky person doth synne in lechary the one with another. All the kinds of pockes be infectiouse.” - Breviary of Healthe Andrew Boord, 1547
  • 20. Sick Report - Frigate “United States” March 17, 1810
  • 21. Dr. Julius Wagner-Jauregg 1927 Nobel Prize for Medicine for his discovery of “the therapeutic value of malaria inoculation in the treatment of dementia paralytica”
  • 22.
  • 23. Syphilis - Penicillin • 1943 - John Mahoney reported first trial of penicillin in syphilis • Four patients with early syphilis given 25,000 units penicillin IM q4h for 8 days • Darkfield became negative within 16 hours • Total dose was 1.2 million units - this remains a magical number in syphilis therapy to this date.
  • 24.
  • 25. Famous Persons with Syphilis • Ivan the Terrible • Peter the Great • Catherine the Great • Henry VIII of England • Fredrich Nietzsche • Albrecht Durer • Benvenuto Cellini • Guy de Maupassant • Benito Mussolini • Giovanni Cassanova • Paul Gauguin • Francisco Goya • Vincent van Gogh • John Keats • Oscar Wilde • Franz Schubert • Moliere • Heinrich Heine
  • 26.
  • 27. 1972 - Peter Buxton, a PHS official, complained to a reporter about an ongoing study of syphilis being conducted in black men living in Alabama.
  • 28. The resulting stories in the NY Times and Washington Star created an uproar
  • 29. Congressional hearings convened and an outrageous story was revealed
  • 30. Tuskegee • 1932: Study begins with about 600 black men (more than 400 of whom had syphilis). – Most are poor and uneducated – Most from Tuskegee, Alabama, an area with the highest syphilis rate in the U.S. • Incentives for enrollment – Free transportation to the hospital – Free hot lunches – Free medicine for any disease other than syphilis – Free burial after autopsies were performed. • By late 1940’s penicillin established as curative for persons with syphilis, yet treatment not provided to these men until decades later.
  • 31. Tuskegee • Understandably, the outrage was enormous, especially in the African-American community • Damage to the relationship with public health community has been enduring and profound. • This legacy of suspicion and distrust has made public health and research efforts in HIV among African-Americans extremely problematic. – Belief among many African-Americans that HIV/AIDS is a form of genocide that may have been created in a laboratory does not seem so outlandish • The Tuskegee study became for many blacks “a symbol of their mistreatment by the medical establishment, a metaphor for deceit, conspiracy, malpractice, and neglect, if not outright racial genocide.”
  • 32. Remnants of the Tuskegee Syphilis Study Effects on University Freshmen: Yet a Possible Barrier to Research Participation? Crystal B. Spivey, MPH, DrPH March 9, 2004 Supported by: R24MD00151 NCMHD
  • 33. Syphilis - Epidemiology • Worldwide >12 million cases of syphilis annually – 90% in the developing world • U.S. cases peaked near the end of WWII, then fell dramatically with the introduction of penicillin • Mini-epidemic in late 1980s and early 1990s, then declining to lowest level ever in 2000 (eradication?) • Significant increase in cases thereafter which continues….
  • 34.
  • 35. Syphilis—Reported Cases by Stage of Infection, United States, 1941–2011 2011-Fig 36. SR
  • 36. Primary and Secondary Syphilis—Rates by Sex and Male-to-Female Rate Ratios, United States, 1990– 2011 2011-Fig 38. SR
  • 37. Primary and Secondary Syphilis—Rates by Race/Ethnicity, United States, 2002–2011 2011-Fig 45. SR
  • 38. Primary and Secondary Syphilis—Reported Cases* by Sex, Sexual Behavior, and Race/Ethnicity, United States, 2011 *Of the reported male cases of primary and secondary syphilis, 17.0% were missing sex of sex partner information; 2.4% of sex partner data were missing race/ethnicity data. †MSW=men who have sex with women only; MSM=men who have sex with men; 2011-Fig 47. SR
  • 39. Primary and Secondary Syphilis—Rates by Region, United States, 2002–2011 2011-Fig 39. SR
  • 40.
  • 41.
  • 42.
  • 43. Trends in Internet Use for Sexual Encounters by MSM with Syphilis: 2001 - 2003 17.4 20.8 26.7 0 5 10 15 20 25 30 PercentInternetusers 2001 2002 2003 Report Year (N=899) LAC - DHS
  • 44.
  • 45. “The pleasure is momentary, the position ridiculous, and the expense damnable” -Attributed to Lord Chesterfield
  • 46. Pathophysiology  Syphilis is caused by the spirochete Treponema pallidum.  It initiates infection after gaining access to subcutaneous tissues via abrasions that occur during sexual intercourse  Can initiate infection on intact skin
  • 47. Pathophysiology  After invading the subcutaneous tissue the organism establishes the chancre.  Some organisms also establish infection in regional lymph nodes during early local replication.
  • 48. Pathophysiology  Nearly all cases of syphilis are sexually acquired (aside from congenital syphilis)  Transmission rate during primary and secondary syphilis is about 30% and requires exposure to open lesions – either primary chancre or mucocutaneous lesions.  The incubation period varies but ranges from 10 – 90 days.
  • 49. Clinical manifestations: Primary syphilis  The initial clinical manifestations is the primary chancre.  Usually painless, which distinguishes it from other causes of genital ulcers: herpes simplex (genital herpes) and Hemophilus ducreyi (chancroid).  May be indurated (collar button)  Most often heals without treatment over a period of a few weeks.
  • 50. Secondary syphilis  If untreated, approximately 25% of patients will go on to develop systemic symptoms  Rash  Fever  Headache  Malaise  Diffuse lymphadenopathy  Alopecia
  • 52. Secondary Syphilis - Patchy Alopecia
  • 53. Late vs. Latent syphilis  Latent syphilis refers to patients without symptoms who have positive serologic testing for syphilis.  Early latent refers to duration less than one year  Late latent refers to duration greater than one year or of unknown duration  Late or tertiary syphilis refers to the group of clinical manifestations that may occur anywhere between 1 and 30 years after infection when the infection is not treated.
  • 54. Tertiary syphilis  Patients may not have experienced symptomatic primary or secondary syphilis prior to developing tertiary syphilis  Most common manifestations are central nervous system, the cardiovascular system, or the skin and subcutaneous tissues (gummas).
  • 55. Neurosyphilis  Neurosyphilis refers to invasion of the CSF by T. pallidum and can occur at any stage of disease  Early in the disease the most common manifestations are asymptomatic meningitis, symptomatic meningitis, and meningovascular disease.  Late in disease, the most common forms involve the brain and spinal cord parenchyma (general paresis [progressive dementia] and tabes dorsalis).
  • 56. Asymptomatic neurosyphilis  By definition, no symptoms or signs of CNS involvement  Can occur within weeks of infection  Characterized by lymphocytic pleocytosis typically <100 cells/µL, an elevated protein concentration usually <100 mg/dL, a reactive VDRL, or a combination of these.  CSF WBC count >10 lymphocytes per microliter + a protein concentration >45 mg/dL in patients without HIV infection is suggestive  Reactive CSF-VDRL is diagnostic of neurosyphilis  In HIV-infected patients with a negative CSF VDRL the diagnosis is challenging since a mild CSF pleocytosis and elevated protein are relatively common in HIV-infected patients
  • 57. Syphilis and HIV  HIV and syphilis are prevalent in the same risk groups, particularly men who have sex with men (MSM)  The two infections can enhance the acquisition and transmission of one other  Neurosyphilis may be more common in persons co-infected with HIV; there have been many case reports of HIV+ patients rapidly progressing from early syphilis to neurosyphilis  Failure of benzathine penicillin to cross blood-brain barrier may be more problematic in HIV-infected persons with syphilis
  • 58. Syphilis and HIV Infection • More florid presentations of early syphilis • More rapid progression to symptomatic neurosyphilis after early infection • Risk of benzathine penicillin treatment failure - CNS • Delayed seroconversion (RPR, FTA-Abs) in early syphilis • Potential for sero-reversion of treponemal serology • Unusually high titer non-treponemal serologic results Nonetheless, most cases managed as if HIV- negative
  • 59. Syphilis and HIV Aberrant Serologic Testing for Syphilis • HIV-positive patients with syphilis often have higher titers of reagin antibodies than HIV-uninfected individuals. • However, some patients with very late stage HIV infection have delayed or absent serologic responses (i.e., false negative tests), or are more likely to lose their reactivity after appropriate therapy. • This variability is thought to reflect abnormally active B-cell function during early HIV infection and B-cell failure during late stage infection.
  • 60. Syphilis and HIV Aberrant Serologic Testing for Syphilis • The rate of decline of nontreponemal titers following successful therapy may also be influenced by HIV co-infection, falling more slowly in those with HIV infection. • In a large, randomized prospective study of persons with early syphilis, the HIV-coinfected group had a higher rate of serologically defined treatment failure. • However, in this and other studies, all patients responded clinically to treatment, suggesting that the significance of the diminished serologic response may be minimal.
  • 61.
  • 62. Diagnosis  T. pallidum cannot be grown in culture, so other methods have been used to identify organisms  Dark field microscopy - direct visualization of spirochetes taken directly from lesions  Direct fluorescent antibody testing was previously used – detected T. pallidum-specific antigens  Neither test currently available  More often, serologic tests are used, traditionally:  Nontreponemal tests (VDRL and RPR) measure reactivity of serum from patients with syphilis to a cardiolipin-cholesterol-lecithin antigen. They measure IgG and IgM antibodies and are reported as titers.  Treponemal tests (FTA-ABS, MHA- TP and TPPA) are based upon the detection of antibodies directed against treponemal cellular components.
  • 63.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69.
  • 70.
  • 71. If asymptomatic, who needs LP?  Study of 239 patients with syphilis who underwent LP analyzed to determine predictors for neurosyphilis  Neurosyphilis defined as +CSF VDRL and/or CSF WBC > 20 cells/ml  43 of 239 met diagnostic criteria. Predictors:  Serum RPR > 1:32  HIV infection with CD4 count < 350 cells /mm3 Marra et al. J Infect Dis 2004;189:369-76
  • 72.
  • 74. Treatment  T. pallidum remains highly sensitive to penicillin and no resistance has been reported to date despite several decades of use
  • 75. Treatment  Successful therapy requires maintenance of prolonged low concentrations of drug in infected tissues  Depot preparations such as benzathine penicillin accomplish this goal but do not penetrate CNS  Standard therapy for primary, secondary, or early latent syphilis is benzathene penicillin G (one dose 2.4 million units IM)  If the patient has had syphilis of greater than 1 year duration or if duration is unknown, treatment should be benzathene penicillin G 2.4 million units IM x 3 weekly doses  Neurosyphilis and ocular syphilis: 18 to 24 million units per day, administered as 3 to 4 million units IV every four hours or continuous infusion, for 10 to 14 days
  • 76.
  • 77. “Half of what we have taught you is wrong. Unfortunately, we do not know which half.” – C. Sidney Burwell, M.D. Address to the graduation class Harvard Medical School